GROUP ONE TRADING, L.P. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is and the CUSIP is 812578902. A total of 2 filers reported holding SEATTLE GENETICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$9,256,000
+137.9%
47,300
+106.6%
0.03%
+61.1%
Q2 2020$3,891,000
-1.4%
22,900
-33.0%
0.02%
-43.8%
Q1 2020$3,946,000
+34.4%
34,200
+33.1%
0.03%
+60.0%
Q4 2019$2,936,000
+4.5%
25,700
-21.9%
0.02%
-13.0%
Q3 2019$2,810,000
+346.0%
32,900
+261.5%
0.02%
+283.3%
Q2 2019$630,000
-30.6%
9,100
-26.6%
0.01%
-40.0%
Q1 2019$908,000
+493.5%
12,400
+359.3%
0.01%
+900.0%
Q4 2018$153,000
-0.6%
2,700
+35.0%
0.00%0.0%
Q3 2018$154,000
-91.2%
2,000
-92.4%
0.00%
-93.3%
Q2 2018$1,746,000
+76.5%
26,300
+39.2%
0.02%
+50.0%
Q1 2018$989,000
-23.6%
18,900
-21.9%
0.01%
+11.1%
Q4 2017$1,295,000
+27.3%
24,200
+29.4%
0.01%0.0%
Q3 2017$1,017,000
+4.5%
18,700
-0.5%
0.01%
-10.0%
Q2 2017$973,000
-14.5%
18,800
+3.9%
0.01%
-23.1%
Q1 2017$1,138,000
-45.1%
18,100
-53.9%
0.01%
-35.0%
Q4 2016$2,074,000
+610.3%
39,300
+627.8%
0.02%
+566.7%
Q3 2016$292,000
-72.7%
5,400
-79.6%
0.00%
-76.9%
Q2 2016$1,071,000
+35.6%
26,500
+17.8%
0.01%
+18.2%
Q1 2016$790,000
-62.4%
22,500
-51.9%
0.01%
-56.0%
Q4 2015$2,100,000
+21.8%
46,800
+4.7%
0.02%
+4.2%
Q3 2015$1,724,000
-18.9%
44,700
+1.8%
0.02%
-20.0%
Q2 2015$2,125,000
+545.9%
43,900
+372.0%
0.03%
+500.0%
Q1 2015$329,000
-75.5%
9,300
-77.8%
0.01%
-75.0%
Q4 2014$1,343,000
-22.6%
41,800
-10.5%
0.02%
-25.9%
Q3 2014$1,736,000
+212.8%
46,700
+222.1%
0.03%
+200.0%
Q2 2014$555,000
-58.3%
14,500
-50.3%
0.01%
-59.1%
Q1 2014$1,330,000
-26.2%
29,200
-35.4%
0.02%
-18.5%
Q4 2013$1,803,000
-3.4%
45,200
+6.1%
0.03%
-25.0%
Q3 2013$1,867,000
+22.6%
42,600
-12.0%
0.04%
-5.3%
Q2 2013$1,523,00048,4000.04%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 24,200$1,295,0000.01%
SIMPLEX TRADING, LLC 226$16,0000.00%
JPMORGAN CHASE & CO 36,000$1,926,0000.00%
View complete list of SEATTLE GENETICS INC shareholders